PAMP
AIMT

Polar Asset Management Partners’s Aimmune Therapeutics AIMT Stock Holding History

Polar Asset Management Partners’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-155,500
Closed -$5.36M – 1040
2020
Q3 		$5.36M Buy
+155,500
New +$3.31M 0.07% 211

Polar Asset Management Partners's AIMT Position: Q4 2020 in Review

Polar Asset Management Partners sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 155,500 shares — an estimated $5.36M sold.

Polar Asset Management Partners first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $5.36M in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • Polar Asset Management Partners reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Polar Asset Management Partners sold 155,500 Aimmune Therapeutics shares in Q4 2020, an estimated $5.36M.
  • Polar Asset Management Partners first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
  • Polar Asset Management Partners's Aimmune Therapeutics position peaked at $5.36M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Polar Asset Management Partners's 13F filing for Q4 2020, filed 16 Feb 2021.